RARE FY2025 SEC EDGAR DEF 14A #89 of 168 in industry

Ultragenyx Pharmaceutical Inc. CEO pay ratio

The CEO earned $11.5M in FY2025 against median worker pay of $302,376 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-03-27
Industry
Chemicals & Pharmaceuticals
Industry rank
#89/168

Data updated August 2026

Subscribe to Ultragenyx Pharmaceutical Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
38:1
Below Average (Scale: 0–1000:1)
CEO pay
$11.5M
Median worker
$302,376

Answer first

Ultragenyx Pharmaceutical Inc.'s FY2025 CEO total of $11.5M ranks #438 of 1,423 complete filings; its 38:1 pay ratio ranks #1073. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $302,376. Industry placement uses the FY2025 SIC-28 peer cohort (# 89 of 168, 48th percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#438
$11.5M of 1,423 FY2025
Ratio rank
#1073
38:1 of 1,423
Industry pct
48th
below the industry median pay ratio

How Ultragenyx Pharmaceutical Inc. ranks nationally

Ultragenyx Pharmaceutical Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$11,490,288 Top 31% higher than 69% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). This entry sits in this band. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Ultragenyx Pharmaceutical Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($11.5M) against pay ratio (38:1) for Ultragenyx Pharmaceutical Inc. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both1634542.85801442.9996834314135243.118302143.235.7:137.4:139:140.6:142.3:1CEO total payPay ratio (CEO : median worker)Ultragenyx Pharmaceutical Inc., CEO total pay: 11490288 · Pay ratio (CEO : median worker): 38:1Ultragenyx Pharmaceutical Inc.Cryoport, Inc., CEO total pay: 2392161 · Pay ratio (CEO : median worker): 37:1Cryoport, Inc.Xenon Pharmaceuticals Inc., CEO total pay: 9118206 · Pay ratio (CEO : median worker): 37:1Xenon Pharmaceuticals Inc.BridgeBio Pharma, Inc., CEO total pay: 14944585 · Pay ratio (CEO : median worker): 37:1BridgeBio Pharma, Inc.Rhythm Pharmaceuticals, Inc., CEO total pay: 17544525 · Pay ratio (CEO : median worker): 36:1Rhythm Pharmaceuticals, Inc.
Ultragenyx Pharmaceutical Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Ultragenyx Pharmaceutical Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Ultragenyx Pharmaceutical Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
38:1
FY2025
vs prior FY
-4:1
from FY2024 42:1
CEO $ YoY
-16%
$11.5M latest
Filings shown
5
FY2021–2025
Ultragenyx Pharmaceutical Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $9.4M - $294,092 32:1 -
2022 $12.3M +30% $314,351 39:1 +7:1
2023 $13.1M +6.8% $353,878 37:1 -2:1
2024 $13.7M +4.3% $325,295 42:1 +5:1
2025 $11.5M -16% $302,376 38:1 -4:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1515673, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
38:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$11.5M
Companies in Industry
168
vs. Industry Median
Below
#89 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Ultragenyx Pharmaceutical Inc.: MODEST · HEAVY pay ratio

Ultragenyx Pharmaceutical Inc.'s 38:1 ratio ranks #1073 of 1,423 FY2025 complete filings (lower third by ratio). the CEO earned 38× the median employee ($302,376) in FY2025.

Median employee $302,376 (ELITE-MED); MODEST · HEAVY stamps put about 38 median-wage years per CEO year.

CEO Total Pay

$11.5M

FY2025 Summary Compensation, above median

Pay Ratio

38:1

Below typical

Ultragenyx Pharmaceutical Inc. in the lower-ratio third

Ultragenyx Pharmaceutical Inc.'s 38:1 ratio ranks #1073 of 1,423 FY2025 complete filings (lower third by ratio). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Ultragenyx Pharmaceutical Inc.'s $11.5M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #438 and ratio rank #1073 split - treat 38:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$11.5M
Median Employee Pay
$302,376
Pay Ratio
38:1
Filing Date
2026-03-27

Company Info

Ticker
RARE
CIK
1515673
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1515673, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Ultragenyx Pharmaceutical Inc.'s 38:1 ratio ranks #1073 of 1,423 FY2025 complete filings (lower third by ratio).

Read with Ultragenyx Pharmaceutical Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · ELITE-MED.

Gray Media, Inc · HEAVY

ABS(ceo_total_comp) peer at $11.5M (Δ $6K heavier vs Ultragenyx Pharmaceutical Inc.); STEEP · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
Jackson Financial Inc. · HEAVY

ABS(ceo_total_comp) peer at $11.5M (Δ $12K lighter vs Ultragenyx Pharmaceutical Inc.); MID · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
Dauch Corp · HEAVY

ABS(ceo_total_comp) peer at $11.5M (Δ $25K heavier vs Ultragenyx Pharmaceutical Inc.); STEEP · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
Fortinet, Inc. · HEAVY

ABS(ceo_total_comp) peer at $11.5M (Δ $32K lighter vs Ultragenyx Pharmaceutical Inc.); MODEST · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Cryoport, Inc. (SIC 28 pole)

Cryoport, Inc. stamps MODEST · MID$ nearest in-SIC by ABS(pay_ratio) to Ultragenyx Pharmaceutical Inc.'s MODEST filing.
National dual ranks · #438/#1073

Ultragenyx Pharmaceutical Inc.'s FY2025 package sits #438 by CEO dollars and #1073 by ratio under HEAVY · MODEST.
Ratio primer · MODEST

Ultragenyx Pharmaceutical Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Ultragenyx Pharmaceutical Inc. (CIK 1515673), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.